News

News
Other news

ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications

Read full story
Other news

XWPharma Names Michael M. Morrissey, PhD to Board of Directors

Read full story
Other news

Analytics 4 Life and Actelion to Develop New Diagnostics for Pulmonary Hypertension

Read full story
JNJ Press releases

Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab

Read full story
JNJ Press releases

Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy

Read full story
JNJ Press releases

Johnson & Johnson Innovation announces winners of the Seoul Innovation QuickFire Challenge in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
JNJ Press releases

Nico Vandervelpen nominated in Bloomberg50 list

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Launch of JLABS @ Shanghai in Collaboration with Shanghai Municipal Government, Pudong New Area Government and Shanghai Pharma Engine Company Ltd

Read full story
JNJ Press releases

eTheRNA joins the JLINX Community

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

Read full story
JNJ Press releases

Johnson & Johnson Innovation Establishes Network of Partnering Offices in UK Life Sciences Clusters

Read full story